Climb Bio, Inc. Common Stock

CLYMNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
15.30 USD
↘ 0.78 (4.85%)🟢LIVE (AS OF 03:29 PM EDT)
🟢Market: OPEN

Shares of Climb Bio, Inc. Common Stock (CLYM) are trading at $15.30. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. CLYM is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 26, 2026.

Open?$16.09
High?$16.39
Low?$15.09
Prev. Close?$16.08
Volume?957.8K
Avg. Volume?1.2M
VWAP?$15.55
Rel. Volume?0.83x
Bid / Ask
Bid?$15.28 × 100
Ask?$15.34 × 100
Spread?$0.06
Midpoint?$15.31
Valuation & Ratios
Market Cap?923.6M
Shares Out?57.4M
Float?20.0M
Float %?41.8%
P/E Ratio?N/A
P/B Ratio?3.86
EPS?-$1.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
29
Market Cap
923.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.climbbio.com
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?80.34Safe
Confidence?41%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?37.88%Squeeze Risk
Short Interest?7.6M
Days to Cover?6.3
Free Float20.0M
Avg Daily Volume1.2M
Settlement Date2026-08-14
Financial Health
Current Ratio?31.45Strong
Quick Ratio?31.45Strong
Cash Ratio?7.43Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
46
3.86FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-13.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-24.1%WEAK▾
ROA?
S&P
3
-23.4%WEAK▾
Cash Flow & Enterprise
FCF?$-53068000
Enterprise Value?$879.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist